Stakeholder engagement

Establishing an open and constructive dialogue with internal and external stakeholders is essential for creating sustainable value and building long-term trust. By actively listening to stakeholder feedback, we gain insights that help shape our strategy and inform risk management. Engagement is conducted regularly through formal meetings, consultations and surveys as well as via channels such as websites and publications.

The resulting insights inform every stage of our products’ life cycle – from early design and research and development to manufacturing, distribution and end-of-life considerations. Stakeholder input also guides our global business operations and supports our collaboration with patient communities, healthcare professionals and governments to strengthen healthcare systems and improve access to care.

Our key stakeholder groups and how we engage with them:

Patients
Purpose of the engagement	Main engagement channels	How we reflect stakeholders’ interests in our work
To understand patient needs and expectations, in line with our purpose of ‘Doing now what patients need next’ and to ensure that our medicines and diagnostic solutions address real-world healthcare challenges.	The International Experience Exchange with Patient Organisations and other collaborations with patient organisations and advocacy groups.	Insights from patient engagement inform disease area strategies, the design of clinical trials and the development of products and services. They also shape our policy dialogue, access approaches and commercialisation planning.

Employees
Purpose of the engagement	Main engagement channels	How we reflect stakeholders’ interests in our work
To foster an inclusive and safe workplace that enables our people to thrive and develop their professional growth.	Global Employee Opinion Survey, town halls, focus groups, performance reviews and works councils such as the Roche Europe Forum.	Feedback from our employees is used to enhance employee experience, well-being initiatives and development programmes, and is integrated into leadership and organisational decisions

Regulatory and industry bodies
Purpose of the engagement	Main engagement channels	How we reflect stakeholders’ interests in our work
To contribute to policy and regulatory discussions that sustain innovation and improve access to healthcare.	Regular dialogue with the authorities, participation in industry associations and contribution to consultations and health technology assessments.	Stakeholder perspectives influence Roche’s positions on regulatory changes and healthcare policies and guide our collaborative efforts to strengthen healthcare systems.

Regulatory and industry bodies
Purpose of the engagement	Main engagement channels	How we reflect stakeholders’ interests in our work
To ensure appropriate use of our medicines and diagnostic solutions and to gather feedback that enhances patient care.	Scientific congresses, advisory boards, clinical trial steering committees.	Insights from healthcare professionals inform product profiles, development plans and disease awareness activities, supporting responsible prescribing and improved patient care.

Suppliers
Purpose of the engagement	Main engagement channels	How we reflect stakeholders’ interests in our work
To promote responsible business conduct, environmental stewardship and resilience across our supply chain.	Supplier audits, sustainability assurance visits, training workshops and collaborative initiatives such as the Pharmaceutical Supply Chain Initiative.	Partnership with our suppliers supports improvements in supplier practices, drives decarbonisation efforts and strengthens compliance with the Roche Supplier Code of Conduct.

Communities and NGOs
Purpose of the engagement	Main engagement channels	How we reflect stakeholders’ interests in our work
To support local development, advance equitable health outcomes and strengthen social impact.	Collaboration with NGOs, employee volunteering, donations and community projects, as well as long-standing initiatives in science, education, arts, culture and the environment.	Engagement with communities and NGOs ensures that our contributions respond to local needs and create lasting value in health, education and the environment areas.

Investors
Purpose of the engagement	Main engagement channels	How we reflect stakeholders’ interests in our work
To ensure transparency on our strategy, performance and sustainability progress, and to maintain long-term trust.	Annual General Meeting, investor briefings and the Roche Annual Report.	Feedback from investors informs our disclosure priorities and reinforces Roche’s focus on innovation, performance and long-term value creation.

Stakeholder engagement

Our key stakeholder groups and how we engage with them:

Downloads

Supplier Code of Conduct

Memberships

Working with Government Officials Guidelines

Working with Patient Groups Position

Related links

InvestorsInvestors

Annual General MeetingAbout Roche

Working with Patient OrganisationsAbout Roche

Clinical trialsInnovation

MediaMedia

PartneringInnovation

Roche Global CitizenshipAbout Roche

Roche Venture FundRoche Venture Fund

Stakeholder engagement

Our key stakeholder groups and how we engage with them:

Patients

Employees

Regulatory and industry bodies

Healthcare professionals

Suppliers

Communities and NGOs

Investors

Downloads

Supplier Code of Conduct

Memberships

Working with Government Officials Guidelines

Working with Patient Groups Position

Related links

InvestorsInvestors

Annual General MeetingAbout Roche

Working with Patient OrganisationsAbout Roche

Clinical trialsInnovation

MediaMedia

PartneringInnovation

Roche Global CitizenshipAbout Roche

Roche Venture FundRoche Venture Fund